Is mycophenolate mofetil superior to pulse intravenous cyclophosphamide for induction therapy of proliferative lupus nephritis in Egyptian patients?

被引:0
|
作者
Eid M. El-Shafey
Said H. Abdou
Mohamed M. Shareef
机构
[1] Tanta University Hospitals,Division of Nephrology, Department of Internal Medicine
[2] Tanta University,Department of Clinical Pathology
[3] Tanta University,Department of Pathology, Faculty of Medicine
[4] Tanta University,undefined
来源
关键词
Intravenous cyclophosphamide (IVC); Mycophenolate mofetil; Proliferative lupus nephritis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:214 / 221
页数:7
相关论文
共 50 条
  • [1] Is mycophenolate mofetil superior to pulse intravenous cyclophosphamide for induction therapy of proliferative lupus nephritis in Egyptian patients?
    El-Shafey, Eid M.
    Abdou, Said H.
    Shareef, Mohamed M.
    [J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2010, 14 (03) : 214 - 221
  • [2] Efficacy and Safety of Mycophenolate Mofetil Versus Intravenous Pulse Cyclophosphamide as Induction Therapy in Proliferative Lupus Nephritis
    Gadakchi, Leyla
    Hajialilo, Mehrzad
    Nakhjavani, Mohammad-Reza
    Azar, Sima Abedi
    Kolahi, Sousan
    Gojazadeh, Morteza
    Ebrahimi, Ali-asghar
    Mahdavi, Aida Malek
    Noshad, Hamid
    Khabbazi, Alireza
    [J]. IRANIAN JOURNAL OF KIDNEY DISEASES, 2018, 12 (05) : 288 - 292
  • [3] Comment on: Efficacy and Safety of Mycophenolate Mofetil versus Intravenous Pulse Cyclophosphamide as Induction Therapy in Proliferative Lupus Nephritis
    Ziaie, Shadi
    Moradi, Omid
    Saffaei, Ali
    [J]. IRANIAN JOURNAL OF KIDNEY DISEASES, 2019, 13 (05) : 347 - 347
  • [4] Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis
    Ong, LM
    Hooi, LS
    Lim, TO
    Goh, BL
    Ahmad, G
    Ghazalli, R
    Teo, SM
    Wong, HS
    Tan, SY
    Shaariah, W
    Tan, CC
    Morad, Z
    [J]. NEPHROLOGY, 2005, 10 (05) : 504 - 510
  • [5] RANDOMIZED CONTROLLED TRIAL OF PULSE INTRAVENOUS CYCLOPHOSPHAMIDE VERSUS MYCOPHENOLATE MOFETIL IN THE INDUCTION THERAPY OF PROLIFERATIVE LUPUS NEPHRITIS
    Ong, Loke Meng
    Hooi, Lai Seong
    Lim, Teck Onn
    Goh, Bak Leong
    Ahmad, Ghazali
    Ghazalli, Rozina
    Teo, Sue Mei
    Wong, Hin Seng
    Tan, Si Yen
    Shaariah, Wan
    Tan, Chwee Choon
    Morad, Zaki
    [J]. NEPHROLOGY, 2005, 10 : A121 - A121
  • [6] Induction therapy for active lupus nephritis: mycophenolate mofetil is superior to cyclophosphamide
    Jennifer R Elliott
    Susan Manzi
    [J]. Nature Clinical Practice Rheumatology, 2006, 2 : 354 - 355
  • [7] Induction therapy for active lupus nephritis: mycophenolate mofetil is superior to cyclophosphamide
    Elliott, Jennifer R.
    Manzi, Susan
    [J]. NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2006, 2 (07): : 354 - 355
  • [8] Comparison of Mycophenolate Mofetil and Intravenous Cyclophosphamide As Induction Therapy in Korean Patients with Lupus Nephritis.
    Park, Dong-Jin
    Lee, Kyung-Eun
    Kim, Tae-Jong
    Park, Yong-Wook
    Lee, Shin-Seok
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S952 - S953
  • [9] Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis
    Hu, WX
    Liu, ZH
    Chen, HP
    Tang, Z
    Wang, QW
    Shen, KQ
    Li, LS
    [J]. CHINESE MEDICAL JOURNAL, 2002, 115 (05) : 705 - 709
  • [10] Induction Therapy for Pediatric Focal Proliferative Lupus Nephritis: Cyclophosphamide Versus Mycophenolate Mofetil
    Lau, Keith K.
    Ault, Bettina H.
    Jones, Deborah P.
    Butani, Lavjay
    [J]. JOURNAL OF PEDIATRIC HEALTH CARE, 2008, 22 (05) : 282 - 288